2013 AAHA/AAFP Fluid Therapy Guidelines For Dogs And Cats*

1y ago
14 Views
2 Downloads
618.68 KB
11 Pages
Last View : 8d ago
Last Download : 3m ago
Upload by : Shaun Edmunds
Transcription

VETERINARY PRACTICE GUIDELINES2013 AAHA/AAFP Fluid Therapy Guidelines forDogs and Cats*Harold Davis, BA, RVT, VTS (ECC), Tracey Jensen, DVM, DABVP, Anthony Johnson, DVM, DACVECC,Pamela Knowles, CVT, VTS (ECC), Robert Meyer, DVM, DACVAA, Renee Rucinsky, DVM, DAVBP (Feline),Heidi Shafford, DVM, PhD, DACVAAABSTRACTFluid therapy is important for many medical conditions in veterinary patients. The assessment of patient history, chief complaint,physical exam findings, and indicated additional testing will determine the need for fluid therapy. Fluid selection is dictated by thepatient’s needs, including volume, rate, fluid composition required, and location the fluid is needed (e.g., interstitial versusintravascular). Therapy must be individualized, tailored to each patient, and constantly re-evaluated and reformulated accordingto changes in status. Needs may vary according to the existence of either acute or chronic conditions, patient pathology (e.g.,acid-base, oncotic, electrolyte abnormalities), and comorbid conditions. All patients should be assessed for three types of fluiddisturbances: changes in volume, changes in content, and/or changes in distribution. The goals of these guidelines are to assistthe clinician in prioritizing goals, selecting appropriate fluids and rates of administration, and assessing patient response totherapy. These guidelines provide recommendations for fluid administration for anesthetized patients and patients with fluiddisturbances. (J Am Anim Hosp Assoc 2013; 49:149–159. DOI 10.5326/JAAHA-MS-5868)Introductionshould not be considered minimum guidelines. Instead theseThese guidelines will provide practical recommendations forguidelines are recommendations from an AAHA/American Asso-fluid choice, rate, and route of administration. They are or-ciation of Feline Practitioners (AAFP) panel of experts.ganized by general considerations, followed by specific guide-Therapy must be individualized and tailored to each patientlines for perianesthetic fluid therapy and for treatment ofand constantly re-evaluated and reformulated according to changespatients with alterations in body fluid volume, changes in body fluidin status. Fluid selection is dictated by the patient’s needs, in-content, and abnormal distribution of fluid within the body. Pleasecluding volume, rate, and fluid composition required, as well asnote that these guidelines are neither standards of care nor Americanlocation the fluid is needed (interstitial versus intravascular).Animal Hospital Association (AAHA) accreditation standards andFactors to consider include the following:From the University of California Davis, Veterinary Medical Teaching Hospital, Davis, CA (H.D.); Wellington Veterinary Clinic, PC,Wellington, CO (T.J.); Department of Veterinary Clinical Sciences,College of Veterinary Medicine, Purdue University, West Lafayette,IN (A.J.); WestVet Animal Emergency and Specialty Center, GardenCity, ID (P.K.); Mississippi State University College of VeterinaryMedicine, Mississippi State, MS (R.M.); Mid Atlantic Cat Hospital,Cordova, MD (R.R.); and Veterinary Anesthesia Specialists, LLC,Milwaukie, OR (H.S.).AAFP American Association of Feline Practitioners; AAHA American AnimalCorrespondence: shafford@vetanesthesiaspecialists.com (H.S.) and arpest7@hotmail.com (R.R)Hospital Association; BP blood pressure; D5W 5% dextrose in water; DKAdiabetic ketoacidosis; K potassium; KCl potassium chloride; LRS lactatedRinger’s solution*This document is intended as a guideline only. Evidence-based supportfor specific recommendations has been cited whenever possible andappropriate. Other recommendations are based on practical clinical experience and a consensus of expert opinion. Further research is neededto document some of these recommendations. Because each case isdifferent, veterinarians must base their decisions and actions on the bestavailable scientific evidence, in conjunction with their own expertise, knowledge, and experience. These guidelines are supported by a generous educational grant from Abbott Animal Health.ª 2013 by American Animal Hospital AssociationJAAHA.ORG149

···Acute versus chronic conditionsamount of fluid estimated to maintain normal patient fluid bal-Patient pathology (e.g., acid-base balance, oncotic pressure,ance (Table 3). Urine production constitutes the majority of fluidelectrolyte abnormalities)loss in healthy patients.2,3 Maintenance fluid therapy is indicatedComorbid conditionsfor patients that are not eating or drinking, but do not haveA variety of conditions can be effectively managed using threevolume depletion, hypotension, or ongoing losses.types of fluids: a balanced isotonic electrolyte (e.g., a crystalloidReplacement fluids (e.g., LRS) are intended to replace lostsuch as lactated Ringer’s solution [LRS]); a hypotonic solution (e.g.,body fluids and electrolytes. Isotonic polyionic replacementa crystalloid such as 5% dextrose in water [D5W]); and a syntheticcrystalloids such as LRS may be used as either replacement or ascolloid (e.g., a hydroxyethyl starch such as hetastarch or tetrastarch).maintenance fluids. Using replacement solutions for short-termmaintenance fluid therapy typically does not alter electrolyteGeneral Principles and Patient Assessmentbalance; however, electrolyte imbalances can occur in patients withThe assessment of patient history, chief complaint, and physicalrenal disease or in those receiving long-term administration ofexam findings will determine the need for additional testingreplacement solutions for maintenance.and fluid therapy. Assess for the following three types of fluidAdministering replacement solutions such as LRS for maintenance predisposes the patient to hypernatremia and hypokalemiadisturbances:1. Changes in volume (e.g., dehydration, blood loss)because these solutions contain more sodium (Na) and less po-2. Changes in content (e.g., hyperkalemia)tassium (K) than the patient normally loses. Well-hydrated patients3. Changes in distribution (e.g., pleural effusion)with normal renal function are typically able to excrete excess NaThe initial assessment includes evaluation of hydration, tissueand thus do not develop hypernatremia. Hypokalemia may developperfusion, and fluid volume/loss. Items of particular importance inin patients that receive replacement solutions for maintenanceevaluating the need for fluids are described in Table 1. Next,fluid therapy if they are either anorexic or have vomiting or di-develop a treatment plan by first determining the appropriatearrhea because the kidneys do not conserve K very well.4route of fluid administration. Guidelines for route of administration are shown in Table 2.If using a replacement crystalloid solution for maintenancetherapy, monitor serum electrolytes periodically (e.g., q 24 hr).Consider the temperature of the fluids. Body temperatureMaintenance crystalloid solutions are commercially available.(warmed) fluids are useful for large volume resuscitation butAlternatively, fluid made up of equal volumes of replacementprovide limited usefulness at low IV infusion rates. It is not possiblesolution and D5W supplemented with K (i.e., potassium chlorideto provide sufficient heat via IV fluids at limited infusion rates to[KCl], 13–20 mmol/L, which is equivalent to 13–20 mEq/L) would1either meet or exceed heat losses elsewhere.be ideal for replacing normal ongoing losses because of the lowerNa and higher K concentration. Another option for a maintenanceFluids for Maintenance and Replacementfluid solution is to use 0.45% sodium chloride with 13–20 mmol/LWhether administered either during anesthesia or to a sick patient,KCl added.5 Additional resources regarding fluid therapy and typesfluid therapy often begins with the maintenance rate, which is theof fluids are available on the AAHA and AAFP websites.TABLE 1Fluids and AnesthesiaEvaluation and Monitoring Parameters that May Be Used forPatients Receiving Fluid Therapy·· Capillary refill time· Mucous membrane color· Respiratory rate and effort· Lung sounds· Skin turgor· Body weight· Urine output· Mental status· Extremity temperaturePulse rate and quality·· Total protein· Serum lactate· Urine specific gravity· Blood urea nitrogen· Creatinine· Electrolytes· BP· Venous or arterial blood gases· O saturationPacked cell volume/total solids2JAAHA support during the perianesthetic period. Decisions regardingwhether to provide fluids during anesthesia and the type andvolume used depend on many factors, including the patient’ssignalment, physical condition, and the length and type of theprocedure. Advantages of providing perianesthetic fluid therapyfor healthy animals include the following:·Correction of normal ongoing fluid losses, support of cardiovascular function, and ability to maintain whole body fluidvolume during long anesthetic periods·Countering of potential negative physiologic effects associatedwith the anesthetic agents (e.g., hypotension, vasodilation)BP, blood pressure.150One of the most common uses of fluid therapy is for patient49:3 May/Jun 2013

Veterinary Practice GuidelinesTABLE 2Determining the Route of Fluid AdministrationPatient parameterRoute of fluid administrationGastrointestinal tract is functional and no contraindications exist (e.g., vomiting)Anticipated dehydration or mild fluid volume disturbances in an outpatient settingPer osSubcutaneous. Caution: use isotonic crystalloids only. Do not use dextrose,hypotonic (i.e., D5W), or hypertonic solutions. Subcutaneous fluids arebest used to prevent losses and are not adequate for replacement therapyin anything other than very mild dehydrationIV or intraosseousHospitalized patients not eating or drinking normally, anesthetized patients,patients who need rapid and/or large volume fluid administration (e.g., totreat dehydration, shock, hyperthermia, or hypotension)Critical care setting. Used in patients with a need for rapid and/or large volumefluid administration, administration of hypertonic fluids and/or monitoringof central venous pressureCentral IVD5W, 5% dextrose in water.·Continuous flow of fluids through an IV catheter prevents clotconsuming “third space” has never been reliably shown, and, information in the catheter and allows the veterinary team tohumans, blood volume was unchanged after overnight fasting.12quickly identify problems with the catheter prior to needingPreanesthetic Fluids and Preparing the Sick Patientit in an emergencyWhen fluids are provided, continual monitoring of the as-Correct fluid and electrolyte abnormalities in the sick patient assessment parameters is essential (Table 1). The primary risk ofmuch as possible before anesthesia by balancing the need forproviding excessive IV fluids in healthy patients is the potentialpreanesthetic fluid correction with the condition requiring sur-for vascular overload. Current recommendations are to delivergery. For example, patients with uremia benefit from preanesthetic, 10 mL/kg/hr to avoid adverse effects associated with hyper-fluid administration.13 Further, develop a plan for how fluids willvolemia, particularly in cats (due to their smaller blood volume),be used in an anesthesia-related emergency based on individualand all patients anticipated to be under general anesthesia for longcomoribund conditions, such as hypertrophic cardiomyopathy andperiods of time (Table 4).6–8 In the absence of evidence-basedoliguric/polyuric renal disease.anesthesia fluid rates for animals, the authors suggest initiallystarting at 3 mL/kg/hr in cats and 5 mL/kg/hr in dogs. Preoperativevolume loading of normovolemic patients is not recommended.The paradigm of “crystalloid fluids at 10 mL/kg/hr, withMonitoring and Responding to HypotensionDuring AnesthesiaBlood pressure (BP) is the parameter often used to estimate tissuehigher volumes for anesthesia-induced hypotension” is notperfusion, although its accuracy as an indicator of blood flowevidence-based and should be reassessed. Those high fluid ratesis not certain.11,14,15 Hypotension under anesthesia is a frequentmay actually lead to worsened outcomes, including increasedoccurrence, even in healthy anesthetized veterinary patients. Assessbody weight and lung water; decreased pulmonary function; co-excessive anesthetic depth first because it is a common cause ofagulation deficits; reduced gut motility; reduced tissue oxygenation; increased infection rate; increased body weight; and positivefluid balance, with decreases in packed cell volume, total protein9,10concentration, and body temperature.Note that infusion of10–30 mL/kg/hr LRS to isoflurane-anesthetized dogs did notchange either urine production or O2 delivery to tissues.11 A fluid-TABLE 3Recommended Maintenance Fluid Rates (mL/kg/hr)49TABLE 4Recommendations for Anesthetic Fluid Ratesthe maintenance rate plus any necessary replacement rate at· Provide, 10 mL/kg/hramount and type of fluids based on patient assessment and· Adjustmonitoringrate is lower in cats than in dogs, and lower in patients with· Thecardiovascular and renal disease· Reduce fluid administration rate if anesthetic procedure lasts . 1 hrguideline would be to reduce the anesthetic fluid rate by 25% q hr· Auntiltypicalmaintenance rates are reached, provided the patient remains stableCatsDogsFormula: 80 3 body weight (kg)0.75Formula: 132 3 body weight (kg)0.75Rule of thumb for cats for initial rate: 3 mL/kg/hrRule of thumb: 2–3 mL/kg/hrRule of thumb: 2–6 mL/kg/hrRule of thumb for dogs for initial rate: 5 mL/kg/hrJAAHA.ORG151

hypotension.7,16 Exercise caution when using fluid therapy as theMonitor Response to Fluid Therapysole method to correct anesthesia-related hypotension as high ratesIndividual patients’ fluid therapy needs change often. Monitor forof fluids can exacerbate complications rather than prevent them.10,11a resolution of the signs that indicated the patient was in need ofIf relative hypovolemia due to peripheral vasodilation isfluids (Table 1). Monitor for under-administration (e.g., persis-contributing to hypotension in the anesthetized patient, proceed astent increased heart rate, poor pulse quality, hypotension, urinedescribed in the following list:output), and overadministration (e.g., increased respiratory rate··Decrease anesthetic depth and/or inhalant concentration.and effort, peripheral and/or pulmonary edema, weight gain, pul-Provide an IV bolus of an isotonic crystalloid such as LRSmonary crackles [a late indicator]) as described in Table 1. Patients(3–10 mL/kg). Repeat once if needed.with a high risk of fluid overload include those with heart disease,If response is inadequate, consider IV administration of a col-renal disease, and patients receiving fluids via gravity flow.16·loid such as hetastarch. Slowly administer 5–10 mL/kg for dogsCats require very close monitoring. Their smaller bloodand 1–5 mL/kg for cats, titrating to effect to minimize the riskvolume, lower metabolic rate, and higher incidence of occultof vascular overload (measure BP every 3–5 min).9 Colloids arecardiac disease make them less tolerant of high fluid rates.7,18more likely to increase BP than crystalloids.··15If response to crystalloid and/or colloid boluses is inadequateChanges in Fluid Volumeand patient is not hypovolemic, techniques other than fluidtherapy may be needed (e.g., vasopressors or, balanced anes-Examples of Common Disorders Causing Changesthetic techniques).9in Fluid VolumeCaution: Do not use hypotonic solutions to correct hypovole-Dehydration from any causemia or as a fluid bolus because this can lead to hyponatremiaHeart diseaseand water intoxication.Blood lossPostanesthetic Fluid TherapyPostanesthetic fluid administration varies based on intra-anestheticThe physical exam will help determine if the patient has whole bodycomplications and comorbid conditions. Patients that may benefitfluid loss (e.g., dehydration in patients with renal disease), vascularfrom fluid therapy after anesthesia include geriatric patients andspace fluid loss (e.g., hypovolemia due to blood loss), or hypervolemiapatients with either renal disease or ongoing fluid losses from gas-(e.g., heart disease, iatrogenic fluid overload). Acute renal failuretrointestinal disease. Details regarding anesthesia management maypatients, if oliguric/anuric, may be hypervolemic, and if the patient is17be found in the AAHA Anesthesia Guidelines for Dogs and Cats.polyuric they may become hypovolemic. Reassessment of response tofluid therapy will help refine the determination of which fluidFluid Therapy in the Sick Patientcompartment (intravascular or extravascular) has the deficit or excess.First, determine the initial rate and volume based on whether thepatient needs whole body rehydration or vascular space volumeDehydrationexpansion. Next, determine the fluid type based on replacementEstimating the percent dehydration gives the clinician a guide inand maintenance needs as described in the following sections.initial fluid volume needs; however, it must be considered anFluid therapy for disease falls into one or more of the followingestimation only and can be grossly inaccurate due to comorbidthree categories: the need to treat changes in volume, content,conditions such as age and nutritional status (Table 5).and/or distribution.Typically, the goal is to restore normal fluid and electrolyteFluid deficit calculationstatus as soon as possible (within 24 hr) considering the limitationsBody weight (kg) 3 % dehydration ¼ volume (L) to correctof comoribund conditions. Once those issues are addressed, therate, composition, and volume of fluid therapy can be based onGeneral principles for fluid therapy to correct dehydrationongoing losses and maintenance needs. Replace the deficit as wellas normal and abnormal ongoing losses simultaneously (e.g.,include the following:continued vomiting/diarrhea as described below in the “Changes·Add the deficit and ongoing losses to maintenance volumes.in Fluid Volume” section). Accurate dosing is essential, particu-Replace ongoing losses within 2–3 hr of the loss, but replacelarly in small patients, to prevent volume overload.deficit volumes over a longer time period. The typical goal is152JAAHA 49:3 May/Jun 2013

Veterinary Practice GuidelinesTABLE 5Dehydration AssessmentDehydrationPhysical exam findings*EuhydratedMild (w 5%)Euhydrated (normal)Minimal loss of skin turgor, semidry mucousmembranes, normal eyeModerate (w 8%)Moderate loss of skin turgor, dry mucous membranes,weak rapid pulses, enophthalmosSevere (. 10%)Considerable loss of skin turgor, severe enophthalmos,tachycardia, extremely dry mucous membranes,weak/thready pulses, hypotension, altered level ofconsciousness50* Not all animals will exhibit all signs.FIGURE 1Patients may be hypovolemic, dehydrated, hypoten-sive, or a combination of all three.needed in the emergent situation, administer through a second IVcatheter. High K administration rates may lead to cardiac arrest;to restore euhydration within 24 hr (pending limitations oftherefore, do not exceed 0.5 mmol/kg/hr.23–25comorbid conditions such as heart disease).·Frequency of monitoring will depend on the rate at which fluidHow to administer crystalloidsresuscitation is being administered (usually q 15–60 min). As-·sess for euhydration, and avoid fluid overload through monitoring for improvement.·blood volume.26·Shock rates are 80–90 mL/kg IV in dogs and 50–55 mL/kg IV incats.Maintenance solutions low in Na should not be used to replaceextracellular deficits (to correct dehydration) because that mayStandard crystalloid shock doses are essentially one complete·Begin by rapidly administering 25% of the calculated shocklead to hyponatremia and hyperkalemia when those solutionsdose. Reassess the patient for the need to continue at eachare administered in large volumes.25% dose increment.·Monitor signs as described in the patient assessment portion ofHypovolemiathis document. In general, if 50% of the calculated shock vol-Hypovolemia refers to a decreased volume of fluid in the vascularume of isotonic crystalloid has not caused sufficient improve-system with or without whole body fluid depletion. Dehydration isthe depletion of whole body fluid. Hypovolemia and dehydrationment, consider either switching to or adding a colloid.·Once shock is stabilized, replace initial calculated volume def-are not mutually exclusive nor are they always linked. Hypotensionicits over 6–8 hr depending on comorbidities such as renalmay exist separately or along with hypovolemia and dehydrationfunction and cardiac disease.(Figure 1). Hypotension is discussed under “Fluids and Anesthesia.”Common causes of hypovolemia include severe dehydration,rapid fluid loss (gastrointestinal losses, blood, polyuria), and va-When to administer colloids·When it is difficult to administer sufficient volumes of fluidssodilation. Hypovolemic patients have signs of decreased tissuerapidly enough to resuscitate a patient and/or when achievingperfusion, such as abnormal mentation, mucous membrane color,the greatest cardiovascular benefit with the least volume ofcapillary refill time, pulse quality, pulse rate, and/or cold extremityinfused fluids is desirable (e.g., large patient, emergency surgery, large fluid loss).temperature.Hypovolemia due to decreased oncotic pressure is suspectedin patients that have a total protein , 35 g/L (3.5 g/dL) or albumin, 15 g/L (1.5 g/dL).19 Patients in shock may have hypovolemia,decreased BP, and increased lactate (. 2 mmol/L).20–22 Note thatcats in hypovolemic shock may not be tachycardic.Treating hypovolemia·In patients with large volume losses where crystalloids are noteffectively improving or maintaining blood volume restoration.···When increased tissue perfusion and O2 delivery is needed.27·When there is a need for longer duration of effect. PreparationsIf edema develops prior to adequate blood volume restoration.When decreased oncotic pressure is suspected or when the totalprotein is , 35 g/L (or albumin is , 15 g/L).When intravascular volume expansion without whole blood isvary, and some colloids are longer lasting than crystalloids (upneeded, use crystalloids, colloids, or both. IV isotonic crystalloidto 24 hr).28 Use of colloids can prolong the effects of hypertonicfluids are the initial fluid of choice. If electrolytes such as K aresaline administration. The typical hydroxyethyl starch dose forJAAHA.ORG153

the dog is up to 20 mL/kg/24 hr (divide into 5 mL/kg bolusesHypervolemiaand reassess). For the cat, the dose range is 10–20 mL/kg/24 hrHypervolemia can be due to heart failure, renal failure, and/or(typically, 10 mL/kg in 2.5–3 mL/kg boluses).29–31 Titrate theiatrogenic fluid overload. Hypertension is not an indicator ofamount of colloid infused to effect.hypervolemia. Treatment is directed at correcting underlyingdisease (e.g., chronic renal disease, heart disease), decreasing orSimultaneously administering crystalloids and colloidsstopping fluid administration, and (possibly) use of diuretics.·Use this technique when it is necessary to both increase intra-Consider using hypotonic 0.45% sodium chloride as maintenancevascular volume (via colloids) and replenish interstitial deficitsfluid therapy in patients susceptible to volume overload (such as(via crystalloids).those with heart disease) due to the decreased Na load.·Administer colloids at 5–10 mL/kg in the dog and 1–5 mL/kgin the cat. Administer the crystalloids at 40–45 mL/kg in theHyperthermiadog and 25–27 mL/kg in the cat, which is equivalent to ap-Increased body temperature can rapidly lead to dehydration.proximately half the shock dose. Titrate to effect and continu-Treatment includes administering IV replacement fluids whileally reassess clinical parameters to adjust rate and type of fluidmonitoring for overhydration. Subcutaneous fluids are not ade-administered (crystalloid and/or colloid).quate to treat hyperthermia.Changes in Fluid ContentUsing hypertonic saline···To achieve the greatest cardiovascular benefit with the leastvolume of infused fluids (typically reserved for large patientsExamples of Common Disorders Causing Changesor very large volume losses).in Fluid ContentTo achieve translocation of fluids from the interstium to theDiabetesintravascular space (e.g., for initial management of hemorrhage).Renal diseaseIn animals with hemorrhagic hypovolemic shock as a fast-Urinary obstructionacting, low-volume resuscitation. Shock doses of hypertonicsaline are 4–5 mL/kg for the dog and 2–4 mL/kg for the cat.·Direct effects of hypertonic saline last 30–60 min in the vascu-Patients with body fluid content changes include those withlar space before osmotic forces equilibrate between the intra-electrolyte disturbances, blood glucose alterations, anemia, andand extravascular space. Once the patient is stabilized, continuepolycythemia. Patient assessment will dictate patient fluid contentwith crystalloid therapy to replenish the interstitial fluid loss.needs. It is acceptable, and often desirable, to initiate fluid therapyIn conjunction with synthetic colloids to potentiate the effectswith an isotonic balanced crystalloid solution while awaiting theof the hypertonic saline.·28,29Do not use hypertonic saline in cases of either hypernatremiaelectrolyte status of the patient. Tailor definitive fluid therapy as theresults of diagnostic tests become available.or severe dehydration.HyperkalemiaTreating hypovolemia due to blood lossSuspect hyperkalemia in cases of obvious urinary obstruction,The decision of when to use blood products instead of balanceduroabdomen, acute kidney injury, diabetic ketoacidosis (DKA), orelectrolyte solutions is based on the severity of estimated bloodchanges on an electrocardiogram. If life-threatening hyperkalemialoss. Use of blood products is addressed elsewhere.32,33 If bloodis either suspected or present (K . 6 mmol/L), begin fluid therapyproducts are not deemed necessary, note that patients with lowimmediately along with medical therapy for hyperkalemia.35vascular volume (due to either vasodilation or hemorrhage) willThere are several benefits associated with administeringbenefit more from the use of colloids than crystalloids. FollowingK-containing balanced electrolyte solutions pending laboratory15 mL/kg of hemorrhage, even 75 mL/kg of crystalloid will nottest results. Volume expansion associated with the fluid admin-return blood volume to prehemorrhage levels because crystalloidsistration results in hemodilution and lowering of serum K con-are highly redistributed. Large volumes may be needed to achievecentration. The relief of any urinary obstruction results inblood volume restoration goals, and large volumes may be det-kaliuresis that offsets the effect of the administered K. The relativerimental to patients with normal whole body fluid volume butalkalinizing effect of the balanced solution promotes the exchangedecreased vascular volume resulting from acute blood loss.34of K with hydrogen ions as the pH increases toward normal.154JAAHA 49:3 May/Jun 2013

Veterinary Practice GuidelinesMost K-containing balanced electrolyte solutions contain lowerK concentrations than those typically seen in cats with urethrala fluid with Na content similar to the measured plasma Na to keepthe rate of change at an appropriate level.obstruction, so the use of such solutions does not affect blood KIn patients with water intoxication, restrict water and/or usein those cats.36 LRS contains 4 mmol/L, which is typically muchdiuretics with caution. Patients with DKA may have pseudohy-lower than the serum K levels in cats with urethral obstruction.ponatremia associated with osmotic shifts of water followingglucose into the intravascular space. In pseudohyponatremia, a re-Hypokalemialationship exists between serum glucose and serum Na levels: theCharts are available in many texts to aid in K supplementation ofhigher the glucose, the lower the Na. Specifically, for every 100 mg/dLfluids and determination of administration rate. It is essential toincrease in serum glucose over 120 mg/dL, the serum Na will de-mix added KCl thoroughly in the IV bag as inadvertent K over-crease by 1.6 mmol/L.3937doses can occur and are often fatal. Do not exceed an IV administration rate of 0.5 mmol/kg/hr of K.38 If sts along with hypokalemia (e.g., DKA), use potassium phos-Colloid osmotic pressure is related to plasma albumin and proteinphate instead of KCl.levels and governs whether fluid remains in the vascular space. Fluidloss into the pulmonary, pleural, abdominal, intestinal, or interstitialHypernatremiaspaces is uncommon until serum albumin is , 15 g/L or totalHypernatremia may be common, yet mild and clinically silent.protein is , 35 g/L.19,40 Evidence of fluid loss from the vascularCauses of hypernatremia include loss of free water (e.g., throughspace is used in conjunction with either serum albumin or totalwater deprivation), and/or iatrogenically (through the long-termsolid values in determining when to initiate colloid therapy.Guidelines for fluid therapy when treating hypoalbuminemiause [. 24 hr] of replacement crystalloids). Another cause ofhypernatremia is salt toxicity (through oral ingestion of high saltinclude the following:content materials).··Provide for ongoing losses and (in hypotensive patients)volume deficits with a replacement fluid having a Na concentrationNutritional support is critical to treatment of hypoalbuminemia.Plasma administration is often not effective for treatment ofhypoalbuminemia due to the relatively low albumin levels forclose to that of the patient’s serum (e.g., 0.9% saline). Oncethe volume infused. Human serum albumin is costly and canvolume needs have been met, replace the free water deficit withcause serious hypersensitivity reactions.41 Canine albumin is nota hypotonic solution (e.g., D5W). Additionally, for anorexicreadily available in most private practice settings but may bepatients, provide maintenance fluid needs with an isotonic bal-the most efficient means of supplementation when available.42anced electrolyte solution. The cause and duration of clinicalhypernatremia will dictat

Animal Hospital Association (AAHA) accreditation standards and should not be considered minimum guidelines. Instead these guidelines are recommendations from an AAHA/American Asso-ciation of Feline Practitioners (AAFP) panel of experts. Therapy must be individualized and tailored to each patient andconstantlyre .

Related Documents:

the 2020 AAHA/AAFP Feline Vaccination Guidelines and resources through an educational grant to AAHA. † A. E. S. Stone was chair of the 2020 AAHA/AAFP Feline Vaccination Guidelines Task Force. These guidelines were prepared by a Task Force of experts convened by the American Ani

The robust advances in pain management for companion animals underlie the decision of AAHA and AAFP to expand on the information provided in the 2007 AAHA/AAFP Pain Management Guidelines for Dogs and Cats. The 2015 guidelines summarize and offer a discriminating review of much of this new knowledge. Pain management is central to veterinary

3 Why Guidelines Matter Veterinary practice guidelines, such as the recently published 2013 AAHA/AAFP Fluid

AAHA Members 15,131 Veterinarians 15,787 Veterinary assistants and support staff 6,722 Veterinary technicians 3,946 Practice managers 2,589 Other 44,175 TOTAL MEMBERS *Financial and Productivity Pulsepoints, Tenth Edition, AAHA Press, 2019. **As of July 1, 2020 2 Billion purchasing power* 4,511 AAHA-accredited and preaccredited .

AAFP Scientific Assembly. 1991 Fall:15-16. Nussbaum MR. Report on the National Conference of Women, Minority, and New Physicians. 1992 Fall:5, 8. Fogarty JP. News from the AAFP Committees and Commissions. 1993 Summer:9, 18. Yowell C. 1994 AAFP Staff Fellowship Opportunities. 1993 Fall:8. Clark JB. Report from AAFP Leadership Conference. 1993 .

L M A B CVT Revision: December 2006 2007 Sentra CVT FLUID PFP:KLE50 Checking CVT Fluid UCS005XN FLUID LEVEL CHECK Fluid level should be checked with the fluid warmed up to 50 to 80 C (122 to 176 F). 1. Check for fluid leakage. 2. With the engine warmed up, drive the vehicle to warm up the CVT fluid. When ambient temperature is 20 C (68 F .

The AAHA Vaccine Guidelines Are Created These early recommendations prompted the American Animal Hospital Association (AAHA) to assemble a task force. In 2003, the AAHA Canine Vaccine Task Force evaluated the data from these challenges and serological studies and, while noting that the core vaccines had a min-

STP 989 Performance of Protective Clothing: Second Symposium S. Z. Mansdorf, Richard Sager, and Alan P. Nielsen, editors ASTM 1916 Race Street